Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer (2017)
- Authors:
- USP affiliated authors: TIEZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP
- Unidade: FMRP
- DOI: 10.1001/jamaoncol.2017.3290
- Subjects: NEOPLASIAS OVARIANAS; CITOTOXICIDADE IMUNOLÓGICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: JAMA Oncology
- ISSN: 2374-2437
- Volume/Número/Paginação/Ano: v. 3, n. 12, dec., art.e173290, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GOODE, Ellen L. et al. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, v. 3, n. 12, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaoncol.2017.3290. Acesso em: 30 maio 2024. -
APA
Goode, E. L., Sousa, C. B. de, Tiezzi, D. G., Andrade, J. M. de, & Reis, F. J. C. dos. (2017). Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, 3( 12). doi:10.1001/jamaoncol.2017.3290 -
NLM
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2024 maio 30 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290 -
Vancouver
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2024 maio 30 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290 - Impacto prognóstico da recorrência local em pacientes com câncer inicial de mama submetidas a tratamento conservador
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
- Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
- Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Idade como fator independente de prognóstico no câncer de mama
- Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients
Informações sobre o DOI: 10.1001/jamaoncol.2017.3290 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
